The first U.S. Supreme Court patent-related decision of 2019 has confirmed the long standing rule that commercial exploitation of a patentable invention may bar the issuance of a patent in the U.S., even where there is no public disclosure of the invention!
Background
The facts of Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. et al. are relatively simple. Helsinn Healthcare S.A., a Swiss pharma company, partnered with MGI Pharma, Inc. to market and distribute in the U.S. 0.25 mg and 0.75 mg doses of palonosetron, a treatment for chemotherapy-induced nausea and vomiting. Helsinn and MGI signed two agreements, each requiring MGI to keep all proprietary information confidential. The existence of the agreements was publicly announced.
In January 2003, nearly two years after the agreements were entered into, Helsinn filed a provisional patent application covering a .25 mg dose of palonosetron (the “‘219 Patent”). Over the next 10 years, Helsinn filed four patent applications that claimed priority dating back to January 2003. One of those patent applications was in respect of the ‘219 Patent and was filed in 2013.
The respondents, Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. (collectively, “Teva”), sought marketing approval for a generic version of palonosetron. Helsinn sued for infringement of the ‘219 Patent. Teva countered that the ‘219 Patent was invalid because the .25 mg dose was “on sale” more than one year before Helsinn filed the provisional patent application. This, they argued, contravened the Leahy-Smith America Invents Act (the “AIA”), which generally precludes a person from obtaining a patent on an invention that was “in public use, on sale, or otherwise available to the public” more than one year before the inventor filed an application for the patent.
The Supreme Court was tasked with determining whether the .25 mg dose was “on sale” within the meaning of the AIA provision, invalidating the ‘219 Patent. Specifically, it had to consider whether the catchall phrase “or otherwise available to the public” in the AIA provision modified the “on sale” bar in that provision. That is, would a “secret” sale (one where the invention was not publically disclosed) invalidate patentability? Notably, the catchall language was added to the AIA in 2011, though the “on sale” bar had existed in U.S. jurisprudence since the 1800s.
The District Court agreed with Helsinn that the catchall language modified earlier jurisprudence, holding the invention was not “on sale” unless the sale or offer was made to the public. The Federal Circuit reversed the District Court’s decision, concluding that the details of the invention need not be publicly disclosed as long as a sale took place. The Supreme Court granted leave and affirmed the Federal Circuit decision, holding that a sale made before the one-year grace period can qualify to invalidate a patent even where the sale was not disclosed to the public.
Implications for U.S. Patents
To avoid a successful “on sale” attack, U.S. inventors and their attorneys should take care to avoid transactions and agreements regarding patentable inventions that could be interpreted as a “commercial sale or offer for sale”. This may prove difficult in practice given agreements regarding inventions are often entered into well before patent applications are filed (for example, in respect of clinical trials, manufacture of active ingredients for regulatory submissions, etc.).
Canadian Perspective
Paragraph 28.2(1)(a) of the Patent Act provides a “statutory bar” to the issuance of a patent in circumstances where the claimed invention in the patent application was disclosed more than one year before the filing date by the applicant in such a manner that the subject matter became available to the public in Canada or elsewhere.
The Federal Court of Appeal has held that, for the prior disclosure statutory bar to apply so as to prevent the issuance of a patent (or to invalidate a patent), there must be public use or public sale of the invention, anywhere in the world, that amounts to an enabling disclosure (Canwell Enviro-Industries Ltd. et al. v. Baker Petrolite Corp. et al., 2002 FCA 158). Enabling disclosure has been defined as disclosure that would allow a person skilled in the art to derive or reverse engineer the invention from the sold product without exercising inventive skill or undue burden.
Key Takeaway
Even though an “on sale” bar may preclude the issuance of a U.S. patent in the case of a “secret sale”, it may nonetheless be possible to obtain a Canadian patent for the invention if the sale or offer to sale is not an enabling disclosure. For example, a sale in the U.S. one year before the filing of the application under a non-disclosure agreement would likely trigger the “on sale” bar, while such a sale in Canada may not constitute enabling disclosure and thus not trigger the commencement of the one-year grace period.
Authors
Insights
-
Intellectual Property Litigation
Carnegie Hall Takes Trademark Center Stage in Legal Battle
Carnegie Hall has reportedly commenced an action against Carnegie Diner and Café for trademark infringement.In its complaint filed with the United States District Court, Southern District of New York… -
Intellectual Property Litigation
Federal Court of Appeal Reiterates Permissive Approach to Granting Leave to Amend Defective Pleadings
In Bell Canada et al. v. Millennium Funding, Inc. et al., 2025 FCA 153, Bell Canada and Bell Aliant (collectively, “Bell”) appealed an order granting the Respondents’ (collectively, “Millenium… -
Intellectual Property Litigation
Under the Radar, Over the Counter: Goyard's Quiet Battle Against Fake Luxury
Goyard, the Parisian brand established in 1853 and still privately owned, has reportedly faced a surge in counterfeit bags flooding the market. The company refrains from advertising, avoids e-commerce… -
Intellectual Property Litigation
Music to Sheeran’s Ears: Supreme Court Declines to Rehear Marvin Gaye Copyright Suit
The US Supreme Court has declined to revisit a copyright dispute over alleged similarities between Ed Sheeran’s 2014 hit, “Thinking Out Loud”, and Marvin Gaye’s 1973 classic, “Let’s Get It On… -
Intellectual Property Litigation
Federal Court Reaffirms Importance of Viva Voce Testimony
In McCain Foods Limited v. J.R. Simplot Company 2024 FC 1729, the Federal Court considered the circumstances in which an examination for discovery of a person, other than a person examined under Rule… -
Intellectual Property Litigation
Salt‑N‑Pepa Wage Legal Battle to Reclaim Their Recordings
Salt-N-Pepa are reportedly suing their record label, Universal Music Group (“UMG”), to attempt to reclaim rights to their music, including hip-hop staples “Shoop” and “Push It”. As reported by the New…
Featured Work
-
Mergers and Acquisitions
Dayforce to be taken private by Thoma Bravo for US$12.3 billion
Goodmans LLP is advising Dayforce, Inc. as Canadian counsel in connection with its definitive agreement to be taken private by Thoma Bravo in an all-cash transaction with an enterprise value of… -
Mergers and Acquisitions
RF Capital Group to be acquired by iA Financial Corporation in C$597 million all-cash transaction
Goodmans LLP is advising RF Capital Group in connection with its sale to iA Financial Corporation, a Quebec City-based insurance and wealth management company, in an all-cash transaction valued at… -
Mergers and Acquisitions
Apotex acquires CanPrev
Goodmans LLP acted for Apotex Inc. in connection with its acquisition of CanPrev, a leading Canadian provider of vitamins, supplements, and other natural health products… -
Mergers and Acquisitions
Apotex acquires Searchlight Pharma Inc.
Goodmans LLP advised Apotex Inc. in connection with its acquisition of Searchlight Pharma Inc… -
Mergers and Acquisitions
FASHIONPHILE acquires Two Authenticators Business
Goodmans LLP acted for FASHIONPHILE, LLC in connection with its purchase of the assets of Two Authenticators Inc… -
Mergers and Acquisitions
Minute Media acquires STN Video
Goodmans LLP acted for Minute Media, a leading global technology and sports content company, in connection with its acquisition of STN Video, a North American industry leader in sports content…
News & Events
-
Intellectual Property Litigation
Goodmans Once Again Honoured at LMG Life Sciences Americas Awards 2025
We are proud to share the Goodmans Intellectual Property Litigation team has been awarded at the LMG Life Sciences Americas Awards 2025 for the second year in a row!Patent Impact Case of the Year… -
Intellectual Property Litigation
Goodmans Once Again Honoured in the 2025 Edition of Managing IP’s IP STARS
We are pleased to announce the 2025 edition of Managing IP’s IP STARS has recognized Goodmans LLP in Tier 1 for our strengths in Patent Disputes for the eighth year in a row. Our Intellectual… -
Aging and Healthcare
Goodmans Once Again Recognized in the Lexpert Special Edition: Health Sciences 2025
We are pleased to announce the Lexpert Special Edition: Health Sciences 2025 once again features Goodmans lawyers among Canada's top-ranked experts.Congratulations to our 8 featured lawyers:Amalia…